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Phosphatidic acrd (PA) dose-dependently induced superoxrde (0;) production of electropermeabilized human neutrophils but not of intact 
neutrophrls, indrcatmg that PA induces the acttvatron of NADPH oxtdase by actmg on an intracellular target. The 0; production by PA was not 
inhibited by protein kinase C (PKC) inhibitors, such as staurosporine and calphostin C, and an inhibitor of PA phosphohydrolase, propranolol. 
These observations suggest that the activation of the oxidase by PA is independent of the activity of PKC and may dominate the activation by 
dtacylglycerol which is formed from PA via the action of PA phosphohydrolase. Furthermore, the productton by PA, as well as that by phorbol 
myrtstate acetate, was inhibited by cychc AMP and GDPBS. Therefore, PA seems to act at a site downstream of PKC. 
Human neutrophil: Respiratory burst; Electropermeabihzation: Stgnal transduction; Phosphatidic actd: Propranolol 
1. INTRODUCTION 
Neutrophils are important in the host defense against 
microbial infection [l] and for this purpose are equipped 
with an enzymatic complex, NADPH oxidase. which is 
able to catalyze the one-electron reduction of molecular 
oxygen to superoxide (0;). The oxidase is dormant in 
non-activated neutrophils and the signal transduction 
process leading to the activation of the oxidase has been 
extensively studied [2,3]. It is generally accepted that 
binding of agonists to their receptors stimulates phos- 
pholipase C (PLC) through the activation of a GTP- 
binding protein. The PLC hydrolyzes phosphatidylinos- 
itol4,5_bisphosphate to the calcium ion mobilizer, inos- 
itol 1,4,5trisphosphate, and the protein kinase C (PKC) 
activator, 1,2-diacylglycerol (DG). The activation of 
PKC leads to the conversion of the dormant oxidase 
into its active form in an unknown manner. Phospholip- 
ase D (PLD) has been reported to be involved in the 
signaling pathway for the respiratory burst [4-l 51. The 
activated PLD hydrolyzes phospholipid, preferentially 
phosphatidylcholine, into phosphatidic acid (PA). Al- 
though PA is further degraded to DG, a PKC activator, 
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by the action of PA phosphohydrolase, it has also been 
reported that PA itself might be a messenger for the 
respiratory burst [7,12,14,15]. 
Permeabilized neutrophils have been used to investi- 
gate the signaling pathway for the respiratory burst 
because they have pores on the plasma membrane 
which allow the permeation of agents with molecular 
weights below 1,000 Da, and produce 0; on stimulation 
by N-formyl-methionyl-leucyl-phenylalanine. vanadate, 
PKC activators such as phorbol myristate acetate 
(PMA) and L-cc-1-oleoyl-2-acetyl-sn-3-glycerol, ara- 
chidonic acid and SDS [16-211. We have recently re- 
ported that PKC is followed by a GTP-binding protein 
which may be distinct from rat p21 in the signaling 
pathway for the respiratory burst, and cyclic AMP in- 
hibits the pathway between the GTP-binding protein 
and NADPH oxidase, and that the process for activat- 
ing the oxidase by SDS is different from that involving 
PKC [20]. 
In the present study, we characterized the 0, produc- 
tion induced by PA and investigated a step where PA 
acts in the signaling pathway for the respiratory burst 
using electropermeabilized human neutrophils. PA 
dose-dependently induced the 0; production of permea- 
bilized cells and this production was not inhibited by 
PKC inhibitors or an inhibitor of PA phosphohydro- 
lase, propranolol, indicating that the production is inde- 
pendent of PKC activity, and that PA itself may act as 
a messenger for the respiratory burst. PA seems to act 
at a site downstream of PKC because PA-induced 0; 
production, as well as PMA-induced production, was 
inhibited by cyclic AMP and GDP/B. The results also 
suggest that the process for activating the oxidase by PA 
is different from that by SDS. 
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2. MATERIALS AND METHODS 
2.1. Reagents 
Staurosporlne and calphostin C were purchased from Kyowa 
Medex. Tokyo. Japan. NADPH and ATP were from OrIental Yeasts. 
Tokyo, Japan. Phosphatldic acid (PA) prepared from egg yolk leclthm 
and 1_-a-l-oleoyl-2-acet~l-~n-3-glycerol were from Funakoshi Cheml- 
cal, Tokyo. Japan. SDS was from Wako Pure Chemical Industries. 
Osaka, Japan. The followmg materials were obtained from Sigma 
Chemical Co., St. LOUIS. MO. USA: ferricytochrome c, superoxIde 
dlsmutase (SOD). phorbol myrlstate acetate (PMA). propranolol hy- 
drochlorlde. cychc AMP, guanosme-5’-O-[2-thlodlphosphate] 
(GDPBS) All other reagents were of analytlcal grade. PA was dls- 
solved in chloroform, dried under N,. and resuspended m water by 
somcation 
Human neutrophlls were Isolated from a healthy donor as described 
previously [22]. In short. after ehminatlon of erythrocytes by dewtran 
sedlmentatlon followed by a brief hypotomc lysis. the cell suspension 
was crntrlfuged m a Flcoll--sodium isothalamate gradient to separate 
the polymorphonuclear leukocytea from lymphocytes. monocytes and 
platelets. Isolated cells were suspended in a HEPES-buffered salt solu- 
tion. containing 135 mM NaCl. 5 mM KC], 5 mM glucose and 20 mM 
HEPES (pH 7 4). and atored on Ice until use For electropermeabihzd- 
tlon. cells were suspended m an Ice-cold permeabllizatlon medmm 
contaimng 140 mM KC]. 1 mM MgCl:. 1 mM EGTA. 0 193 mM 
CaCl?, 10 mM glucose and 10 mM HEPES (pH 6 7). 
2.3 Cell pcrmeuhllixiror~ 
Permeabilization was performed accordmg to the method of Lu and 
Grinstem [19] except that the Ice-cold permeabihzatlon medium was 
adJusted to pH 6.7 (4°C). Brlefly, 8 x 10h cells were transfered to a 
Blo-Rad Gene Pulser and permeablhzed with two discharges of 5 
kV/cm from a 35,uF capacitor. Between pulses, cells were rapldly 
sedlmented and resuspended m the fresh Ice-cold medium. Permeabll- 
ized cells were aedimented and finally suspended m an assay buffer 
contaimng 140 mM KC]. 1 mM MgCl,. 1 mM EGTA. 0.193 mM 
CaCl,. 10 mM glucose and 10 mM HEPES (pH 6.7 at 37°C) Cells of 
2 x 10” were used for each assay wlthm 15 mm of preparation. 
Ferrlcytochrome c was dissolved as pre\lously described [23]. At 
4°C. 200 mg of ferrlcytochrome L’ was dissolved m 10 ml of a half- 
aaturated solution of sodium acetate After 0.4 ml of acetlc anhydride 
was added and stirred for 30 min. the reaction mixture \vas dialyzed 
at 4°C for 12 h agamst the assay buffer. 
The assay mlxture (1 0 ml) consisted of 50 PM ferricytochrome c, 
1 mM CaCl, and 1 x lOh cells in the HEPES-buffered salt solution 
contaming 135 mM NaCl. 5 mM KC], 5 mM glucose and 20 mM 
HEPES (pH 7.4). Where Indicated, CaCl, was omitted. Cells were 
incubated at 37°C for 5 min and 0; production was Initiated by the 
addition of a stimulant and measured by determinmg the rate of 
superoxide dlsmutase (SOD)-mhibitable ferrlcytochrome c reduction 
at 550-540 nm using a dual-wavelength spectrophotometer (Hitachi 
557). as previously described [22]. The 0: release was calculated usmg 
a molar absorption coefficient of 19,100 Mm’ cm-‘. 
2.6. Assay of 0; production by electroprrmrabrli-etl neutrophtls 
The assay mixture (1.0 ml) consisted of 50 PM acetylated cyto- 
chrome c and 2 x lOh permeabilized cells m assay buffercontaming 140 
mM KC], 1 mM MgCl,. 1 mM EGTA. 0.193 mM CaCl?, 10 mM 
glucose and 10 mM HEPES (pH 6.7 at 37°C). Under this condltlon. 
the Ca’+ concentration m the reaction mixture was about 100 nM [13] 
Cells were incubated at 37°C for 5 mm followed by the addition of 
2 mM NADPH and 1 mM ATP. The production of 0; was Initiated 
by the addition of a stimulant and measured by determmmg the rate 
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of SOD-mhibitable reduction of acetylated cytochrome c at 550-540 
nm using a dual-wavelength spectrophntometer (Hltachl557). The 0; 
release was calculated using a molar absorption coefficient of 19,100 
Mm’ cm-’ Where indicated. permeabilized cells were replaced bq 
Intact cells. 
3. RESULTS 
3.1. 0, production 61‘ phosphutidic acid 
We examined whether phosphatidic acid (PA), pre- 
pared from egg yolk lecithin. induces the 02 production 
of electropermeabilized and intact human neutrophils. 
As shown in Fig. 1, PA dose-dependently induced the 
0; production of permeabilized neutrophils. ATP and 
Mg’+ were absolutely required for the production by PA 
(Table I). On the other hand, intact cells did not pro- 
duce 02 by the addition of PA in the same assay medium 
(Fig. 1). This may not be due to the medium for perme- 
abilized cells because phorbol myristate acetate (PMA) 
induced the production in the medium. In addition, PA 
did not induce the Oj production in intact cells when the 
assay medium was replaced by that for intact cells in the 
presence and absence of 1 mM CaCl,. These results 
suggest that PA acts on an intracellular target. 
3.1. Effects of protein kinase C inhibitors und propru- 
nolo1 on 0, production qf permeabilized neutropllils 
Because it has been proposed that PA is degraded to 
diacylglycerol (DG). which in turn activates PKC. by 
the action of PA phosphohydrolase. we examined the 
effect of protein kinase C (PKC) inhibitors such as stau- 
rosporine and calphostin C on the 0; production to 
show whether PA induces the 0; production via the 
action of PKC. As shown in Table I, 10 nM stauro- 
sporine and 5 ,uM calphostin C completely inhibited 
PMA-induced 0; production, but did not inhibit the 
PA-induced production. These results suggest that the 
0; production by PA is independent of the PKC activ- 
3 
F 
5 
0 
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Fig 1. The 0; productlon of permeabilized and Intact human neutro- 
phils induced by phosphatldlc acid The 0: productlon was measured 
by the assay method for permeabllized cells which IS described m 
section 2. The results are representative of three Independent expert- 
ments. Open circles (a) and closed circles (0) represent the 0; produc- 
tion by permeabllized and intact cells, respectively 
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ity. In the present study, we used staurosporine and the hypothesis that propranolol inhibits PKC, and with 
calphostin C because they inhibit PKC by different our result that the 0; production by PA was not inhib- 
mechanisms [24-261. ited by PKC inhibitors (Table I). 
In connection with the above observations, we also 
examined the effect of propranolol on the 0; produc- 
tion induced by PA because propranolol has been re- 
ported to inhibit PA phosphohydrolase [8,9,12,14,27- 
301. As shown in Fig. 2, the 0; production by 100 ,uglml 
PA, the concentration at which the maximal response 
was induced, was not affected by propranolol. but the 
production by 50 ,@ml PA, the concentration at which 
a quarter of maximal response was induced, was mark- 
edly enhanced by propranolol. These results suggest 
that PA is rapidly degraded by PA phosphohydrolase 
and the inhibition of PA phosphohydrolase by propra- 
nolo1 results in the retention of PA. The rapid degrada- 
tion of PA by PA phosphohydrolase may be one of the 
reasons why a relatively high concentration of PA was 
required to induce the maximal response (Fig. l), while 
L-LX- 1- oleoyl-2-acetyl-sn-3-glycerol at the low concen- 
tration of 4 pug/ml induced the maximal response of 
permeabilized cells (results not shown). Furthermore, 
the result that propranolol had no inhibitory effect on 
the 0; production by PA may suggest that DG formed 
by PA phosphohydrolase does not play a significant 
role in the 0; production when the activation of the 
oxidase is induced by PA. Therefore, the activation by 
PA may dominate the activation by DG generated 
through the action of PA phosphohydrolase. Sozzani et 
al. [31] have recently reported that propranolol inhibits 
not only PA phosphohydrolase but PKC. In fact, 200 
PM propranolol inhibited PMA-induced 0; production 
of permeabilized cells by 47.5 ? 9.3% (n = 4), but did 
not show inhibitory effects on PA-induced 0,. produc- 
tion (Fig. 2). These observations are compatible with 
3.3. Effect of GDPPS and cyclic AMP on 0: production 
by phosphatidic acid 
We further investigated whether PA acts at a site 
downstream of PKC in the signaling pathway involving 
PKC or acts by different mechanisms as does SDS. 
Because cyclic AMP inhibits the 0; production of per- 
meabilized cells induced by PMA but not by SDS, and 
GDPPS inhibits the production by PMA more strongly 
than the production by SDS [20]. we examined the ef- 
fects of GDPPS and cyclic AMP on the 0; production 
induced by PA (Table I). The 0; production by PA, as 
well as that by PMA, was half inhibited by 0.1 mM 
GDPPS and completely inhibited by 1 mM GDPBS. 
while the production by SDS was less sensitive to 
GDP/?S. PA- and PMA-induced 0; production was in- 
hibited about 50% by 0.75 mM cyclic AMP and by more 
than 80% by 3 mM cyclic AMP, but SDS-induced pro- 
duction was not inhibited by cyclic AMP. These results 
and the above observation that PKC inhibitors did not 
affect PA-induced 0; production (Table I) may suggest 
that PA induces the activation of NADPH oxidase at 
a site downstream of PKC. This suggestion was sup- 
ported by the finding that the 0; production by PA was 
not enhanced by the addition of PMA (data not shown). 
4. DISCUSSION 
In the present study, we have directly demonstrated 
Table I 
Effects of vartous agents on the 0; production of penneabtlized neu- 
3 
0 100 200 300 400 
Concentration of propranolol (FM) 
Fig. 2. Effect of propranolol on the 0; production of permeabtlized 
neutrophtls by phosphatidlc acid. The 0; productton was measured 
as described in Fig. 1 except that propranolol at various concentra- 
tions was added to the assay mixture 1 min before the addition of a 
stimulant. The results are representative of three independent experi- 
ments. Open squares (0) and closed squares (m) represent the 0; 
production mduced by phosphatidic acid at the concentration of 100 
fig/ml and 50 ,&ml, respecttvely. 
trophils induced by phosphatidtc acid 
Condttton Stimulants (% of control) 
PA PMA SDS 
- ATP 0.0 0.0 50.8 + 2.9 
_ Mg’+ 0.0 0.0 39.1 + 1.2 
+ 10 nM staurosporine 93.3 f 4.1 0.0 95.0 k 4.1 
+ 5 PM calphostin C 90.0 k 2.4 0.0 98.0 k 1.4 
+ 0.1 mM GDP/?S 50.7 t 3.3 52.1 f 5.7 80.7 f 3.3 
+ 1.0 mM GDPPS 0.0 0.0 29.8 f 1.9 
+ 0.75 mM cyclic AMP 51.2 f 3 6 50.7 k 1 9 100.0 f 0.0 
+ 3.0 mM cyclic AMP 13.0 k 2.9 13.6 k 2.6 100.0 f 0.0 
0; productton was measured as described in sectton 2 Where mdi- 
cated, ATP or Mg’+ was omttted. The permeabtlized neutrophils 
(2 x lO”/ml) were preincubated with indicated agents at 37’C and then 
stimulated by lOO,&ml phosphatidtcactd (PA), 10 ng/ml PMA or 100 
,uM SDS. Staurosporine, GDP/B or cyclic AMP was added to the 
assay mtxture 1 min before the addttton of a stimulant. and calphostm 
C was added 5 min before the addition of a stimulant. The control 
activtties of permeabilized cells by PA. PMA and SDS were 
2.22 f 0.06, 2.22 + 0.05 and 3.80 5 0.19 nmol/min/106 cells, respec- 
tively. The data represent the means + SD. of three separate experi- 
ments. 
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that phosphatidic acid (PA) induces the respiratory 
burst of electropermeabilized human neutrophils. PA 
seems to act on an intracellular target because PA did 
not induce the 0; production of intact cells. Ohtsuka et 
al. [32] have reported that 1,2-didecanoyl-3-sn- 
phosphatidic acid but not PA prepared from egg yolk 
lecithin induces the 0; production of the intact cells. 
which was in accord with our result. 
It is generally accepted that PA, which is generated 
by the action of phospholipase D (PLD). is degraded to 
DG by the action of PA phosphohydrolase, and the DG 
activates PKC. Rossi et al. [14], however, have reported 
that the activation of the NADPH oxidase by N-formyl- 
methionyl-leucyl-phenylalanine correlates with the for- 
mation of PA but not with that of DG. It has also been 
reported that PA is capable of stimulating the NADPH 
oxidase in a cell-free system [I 2,151. Because the 05 
production by PA was not inhibited by PKC inhibitors 
(Table I) and by an inhibitor of PA phosphohydrolase, 
propranolol (Fig. 2) the activation of the NADPH ox- 
idase by PA seems to be independent of the PKC activ- 
ity. and the hypothesis that PA itself acts as a messenger 
for the respiratory burst may be confirmed. 
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The step at which PA is involved in the activation of 
the NADPH oxidase has not been identified. The pres- 
ent study indicates that PA may act at a site down- 
stream of PKC in the signaling pathway involving PKC, 
on the basis of the following observations: (i) the PA- 
induced 0; production was not inhibited by PKC inhib- 
itors (Table I), (ii) the production was not inhibited by 
propranolol (Fig. 3), (iii) the production was inhibited 
by cyclic AMP in a similar dose-dependent manner as 
the production induced by PMA (Table I), (iv) both 
productions were inhibited by GDPj?S in a similar dose- 
dependent manner (Table I), and (v) the 0; production 
by PA was not enhanced by the addition of PMA (data 
not shown). The process for activating the NADPH 
oxidase by PA seems to be different from that by SDS, 
because ATP and Mg’+ were absolutely required for the 
02 production by PA but not by SDS. and SDS-induced 
0, production was not inhibited by cyclic AMP and was 
less sensitive to GDP/?S than PA-induced production 
(Table I). 
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